Controversies in the treatment of wet age-related macular degeneration - Reply

被引：4
|
作者：
Bashshur, Ziad F.
Haddad, Zeina A.
机构：
来源：
AMERICAN JOURNAL OF OPHTHALMOLOGY | 2008年 / 145卷 / 05期
关键词：
D O I：
10.1016/j.ajo.2008.02.020
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：938 / 938
页数：1
相关论文
共 50 条
  • [41] Genetic Risk Evaluation in Wet Age-Related Macular Degeneration Treatment Response
    Chaudhary, Varun
    Brent, Michael
    Lam, Wai-Ching
    Devenyi, Robert
    Teichman, Joshua
    Mak, Michael
    Barbosa, Joshua
    Kaur, Harneel
    Carter, Ronald
    Farrokhyar, Forough
    [J]. OPHTHALMOLOGICA, 2016, 236 (02) : 88 - 94
  • [42] The use of transpupillary thermotherapy in the treatment of wet age-related macular degeneration.
    Tang, J
    Ferrone, PJ
    Harrison, SA
    Fastenberg, DM
    Shakin, EP
    Shakin, JL
    Golub, BM
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S442 - S442
  • [43] Patients' knowledge and perspectives on wet age-related macular degeneration and its treatment
    Kandula, Sushma
    Lamkin, Jeffrey C.
    Albanese, Teresa
    Edward, Deepak P.
    [J]. CLINICAL OPHTHALMOLOGY, 2010, 4 : 375 - 381
  • [44] Objective Visual Assessment of Antiangiogenic Treatment for Wet Age-Related Macular Degeneration
    Baseler, Heidi A.
    Gouws, Andre
    Crossland, Michael D.
    Leung, Carmen
    Tufail, Adnan
    Rubin, Gary S.
    Morland, Antony B.
    [J]. OPTOMETRY AND VISION SCIENCE, 2011, 88 (10) : 1255 - 1261
  • [45] Clinical efficacy and safety of ranibizumab in the treatment of wet age-related macular degeneration
    Desideri, Lorenzo Ferro
    Barra, Fabio
    Ferrero, Simone
    Traverso, Carlo Enrico
    Nicolo, Massimo
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (08) : 735 - 751
  • [46] A syndecan-derived peptide for the treatment of Wet age-related macular degeneration
    De Rossi, G.
    Cristante, E.
    Bland, E.
    Bainbridge, J. W.
    Whiteford, J. R.
    [J]. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2017, 98 (01) : A15 - A15
  • [47] Wet Age-Related Macular Degeneration: Treatment Advances to Reduce the Injection Burden
    Baumal, Caroline R.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2020, 26 (05): : S103 - S111
  • [48] Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration
    Yoon, Yi Sang
    Yoon, Won Tae
    Kim, Jong Woo
    Kim, Chul Gu
    Kim, Jae Hui
    [J]. JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2021, 62 (08): : 1076 - 1083
  • [49] Benchmarking anti-VEGF treatment of wet age-related macular degeneration
    Ponsioen, T. L.
    Tigchelaar-Besling, O. A. M.
    Klaver, C. C. W.
    Verbraak, F. D.
    [J]. ACTA OPHTHALMOLOGICA, 2019, 97 : 38 - 38
  • [50] COST COMPARISON OF WET AGE-RELATED MACULAR DEGENERATION TREATMENT WITH AFLIBERCEPT OR RANIBIZUMAB
    Gerasimova, K.
    Derkach, E., V
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A567 - A567
12345